Your browser doesn't support javascript.
loading
Reproducible disease phenotyping at scale: Example of coronary artery disease in UK Biobank.
Patel, Riyaz S; Denaxas, Spiros; Howe, Laurence J; Eggo, Rosalind M; Shah, Anoop D; Allen, Naomi E; Danesh, John; Hingorani, Aroon; Sudlow, Cathie; Hemingway, Harry.
Afiliação
  • Patel RS; Institute of Cardiovascular Sciences, University College London, London, United Kingdom.
  • Denaxas S; NIHR University College London Biomedical Research Centre, University College London and University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Howe LJ; Health Data Research UK London, University College London, London, United Kingdom.
  • Eggo RM; Institute of Health Informatics, University College London, London, United Kingdom.
  • Shah AD; Institute of Cardiovascular Sciences, University College London, London, United Kingdom.
  • Allen NE; NIHR University College London Biomedical Research Centre, University College London and University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Danesh J; Institute of Health Informatics, University College London, London, United Kingdom.
  • Hingorani A; Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Sudlow C; Health Data Research UK London, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Hemingway H; NIHR University College London Biomedical Research Centre, University College London and University College London Hospitals NHS Foundation Trust, London, United Kingdom.
PLoS One ; 17(4): e0264828, 2022.
Article em En | MEDLINE | ID: mdl-35381005
ABSTRACT
IMPORTANCE A lack of internationally agreed standards for combining available data sources at scale risks inconsistent disease phenotyping limiting research reproducibility.

OBJECTIVE:

To develop and then evaluate if a rules-based algorithm can identify coronary artery disease (CAD) sub-phenotypes using electronic health records (EHR) and questionnaire data from UK Biobank (UKB).

DESIGN:

Case-control and cohort study.

SETTING:

Prospective cohort study of 502K individuals aged 40-69 years recruited between 2006-2010 into the UK Biobank with linked hospitalization and mortality data and genotyping.

PARTICIPANTS:

We included all individuals for phenotyping into 6 predefined CAD phenotypes using hospital admission and procedure codes, mortality records and baseline survey data. Of these, 408,470 unrelated individuals of European descent had a polygenic risk score (PRS) for CAD estimated. EXPOSURE CAD Phenotypes. MAIN OUTCOMES AND

MEASURES:

Association with baseline risk factors, mortality (n = 14,419 over 7.8 years median f/u), and a PRS for CAD.

RESULTS:

The algorithm classified individuals with CAD into prevalent MI (n = 4,900); incident MI (n = 4,621), prevalent CAD without MI (n = 10,910), incident CAD without MI (n = 8,668), prevalent self-reported MI (n = 2,754); prevalent self-reported CAD without MI (n = 5,623), yielding 37,476 individuals with any type of CAD. Risk factors were similar across the six CAD phenotypes, except for fewer men in the self-reported CAD without MI group (46.7% v 70.1% for the overall group). In age- and sex- adjusted survival analyses, mortality was highest following incident MI (HR 6.66, 95% CI 6.07-7.31) and lowest for prevalent self-reported CAD without MI at baseline (HR 1.31, 95% CI 1.15-1.50) compared to disease-free controls. There were similar graded associations across the six phenotypes per SD increase in PRS, with the strongest association for prevalent MI (OR 1.50, 95% CI 1.46-1.55) and the weakest for prevalent self-reported CAD without MI (OR 1.08, 95% CI 1.05-1.12). The algorithm is available in the open phenotype HDR UK phenotype library (https//portal.caliberresearch.org/).

CONCLUSIONS:

An algorithmic, EHR-based approach distinguished six phenotypes of CAD with distinct survival and PRS associations, supporting adoption of open approaches to help standardize CAD phenotyping and its wider potential value for reproducible research in other conditions.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: PLoS One Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: PLoS One Ano de publicação: 2022 Tipo de documento: Article